Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy: results of a Veterans Administration Cooperative Study. Circulation. 1989;80:1190 1197. 18. Mangano DT; Multicenter Study of Perioperative Ischemia Research Group. Aspirin and mortality from coronary bypass surgery. N Engl J Med. 2002;347:1309 1317. doi: 10.1056/NEJMoa020798. 19. Johnson WD, Kayser KL, Hartz AJ, Saedi SF. Aspirin use and survival after coronary bypass surgery. Am Heart J. 1992;123:603 608. 20. Farooq V, Serruys PW, Bourantas C, Vranckx P, Diletti R, Garcia Garcia HM, Holmes DR, Kappetein AP, Mack M, Feldman T, Morice MC, Colombo A, Morel MA, de Vries T, van Es GA, Steyerberg EW, Dawkins KD, Mohr FW, James S, St hle E. Incidence and multivariable corre- lates of long-term mortality in patients treated with surgical or percuta- neous revascularization in the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) trial. Eur Heart J. 2012;33:3105 3113. doi: 10.1093/eurheartj/ehs367. 21. Fremes SE, Levinton C, Naylor CD, Chen E, Christakis GT, Goldman BS. Optimal antithrombotic therapy following aortocoronary bypass: a meta- analysis. Eur J Cardiothorac Surg. 1993;7:169 180. 22. Lim E, Ali Z, Ali A, Routledge T, Edmonds L, Altman DG, Large S. Indirect comparison meta-analysis of aspirin therapy after coronary sur- gery. BMJ. 2003;327:1309. doi: 10.1136/bmj.327.7427.1309. 23. Zimmermann N, Kienzle P, Weber AA, Winter J, Gams E, Schr r K, Hohlfeld T. Aspirin resistance after coronary artery bypass graft- ing. J Thorac Cardiovasc Surg. 2001;121:982 984. doi: 10.1067/ mtc.2001.111416. 24. Bednar F, Tencer T, Plasil P, Paluch Z, Sadilkova L, Prucha M, Kopa M. Evaluation of aspirin s effect on platelet function early after coronary artery bypass grafting. J Cardiothorac Vasc Anesth. 2012;26:575 580. doi: 10.1053/j.jvca.2011.12.004. 25. Buchanan MR, Brister SJ. 